Toggle light / dark theme

EGFRvIII-Specific Chimeric Antigen Receptor T Cells Migrate to and Kill Tumor Deposits Infiltrating the Brain Parenchyma in an Invasive Xenograft Model of Glioblastoma

Sharing for fellow researchers and others who have interest in GBM news.


Glioblastoma (GBM) is the most common primary malignant brain tumor in adults and is uniformly lethal. T-cell-based immunotherapy offers a promising platform for treatment given its potential to specifically target tumor tissue while sparing the normal brain. However, the diffuse and infiltrative nature of these tumors in the brain parenchyma may pose an exceptional hurdle to successful immunotherapy in patients. Areas of invasive tumor are thought to reside behind an intact blood brain barrier, isolating them from effective immunosurveillance and thereby predisposing the development of “immunologically silent” tumor peninsulas. Therefore, it remains unclear if adoptively transferred T cells can migrate to and mediate regression in areas of invasive GBM. One barrier has been the lack of a preclinical mouse model that accurately recapitulates the growth patterns of human GBM in vivo. Here, we demonstrate that D-270 MG xenografts exhibit the classical features of GBM and produce the diffuse and invasive tumors seen in patients. Using this model, we designed experiments to assess whether T cells expressing third-generation chimeric antigen receptors (CARs) targeting the tumor-specific mutation of the epidermal growth factor receptor, EGFRvIII, would localize to and treat invasive intracerebral GBM. EGFRvIII-targeted CAR (EGFRvIII+ CAR) T cells demonstrated in vitro EGFRvIII antigen-specific recognition and reactivity to the D-270 MG cell line, which naturally expresses EGFRvIII. Moreover, when administered systemically, EGFRvIII+ CAR T cells localized to areas of invasive tumor, suppressed tumor growth, and enhanced survival of mice with established intracranial D-270 MG tumors. Together, these data demonstrate that systemically administered T cells are capable of migrating to the invasive edges of GBM to mediate antitumor efficacy and tumor regression.

Glioblastoma (GBM) is the most common form of primary malignant brain tumor in adults and remains one of the most deadly neoplasms. Despite multimodal therapy including maximal surgical resection, radiation, and temozolomide (TMZ), the median overall survival is less than 15 months [1]. Moreover, these therapies are non-specific and are ultimately limited by toxicity to normal tissues [2]. In contrast, immunotherapy promises an exquisitely precise approach, and substantial evidence suggests that T cells can eradicate large, well-established tumors in mice and humans [3] [7].

Chimeric antigen receptors (CARs) represent an emerging technology that combines the variable region of an antibody with T-cell signaling moieties, and can be genetically expressed in T cells to mediate potent, antigen-specific activation. CAR T cells carry the potential to eradicate neoplasms by recognizing tumor cells regardless of major histocompatibility complex (MHC) presentation of target antigen or MHC downregulation in tumors, factors which allow tumor-escape from treatment with ex vivo expanded tumor-infiltrating lymphocytes (TILs) [8] and T-cell receptor (TCR) gene therapy [9], [10].

Brave New World: Mind-Controlled Drones Revolutionizing Sports And Warfare

Pretty cool!


As Brain-Computer Interface is rapidly developed worldwide, mind-controlled drones turn into sports and weapons of today.

Florida University hosted a sporting event that might give a start to a new generation of high-technology sport involving latest trademark inventions of 21st century — drones and consumer-grade brain-computer interface (BCI).

Drones have become a trademark of 21st century, since development of low-weight, high-capacity batteries and small sophisticated electronic controllers allowed to construct fairly cheap yet very easy to control flying device.

Breathtaking Visualization of the Universe Will Make You Feel Like an Ant

Ever notice how maps of the large structures of the Universe look like maps of the brain or a Pollock painting?


On the grandest scale, our universe is a network of galaxies tied together by the force of gravity. Cosmic Web, a new effort led by cosmologists and designers at Northeastern’s Center for Complex Network Research, offers a roadmap toward understanding how all of those tremendous clusters of stars connect—and the visualizations are stunning.

The images below show us several hypothetical architectures for our universe, built from data on 24,000 galaxies. By varying the construction algorithm, the researchers have designed cosmic webs that link up in a number of different ways; based on the size, proximity, and relative velocities of individual galaxies. I call it God View.

“Before, the cosmic web was more like a metaphor,” Kim Albrecht, the designer behind the new visualizations told Gizmodo. “This is the first time somebody has made these calculations and thought about it as an actual network.”

Patents remind us that Magic Leap is powered by tiny projectors, not magic

Over the past few days, Wired has published some articles that give us the closest look yet at the ambitious, enigmatic augmented reality company called Magic Leap. They’ve left us with both a lot of fascinating possibilities and a lot of questions, because most of Magic Leap’s technological explanations are couched in the language of either science fiction or, well, magic. As poetic as “[talking] to the GPU of the brain” and “dreaming with your eyes open” sounds, this is probably the clearest and most interesting description of Magic Leap’s work in the piece:

New protein injection reverses Alzheimer’s symptoms in mice in just one week

“IL-33 is a protein produced by various cell types in the body and is particularly abundant in the central nervous system (brain and spinal cord),” says lead researcher, Eddy Liew from the University of Glasgow in the UK. “We found that injection of IL-33 into aged APP/PS1 mice rapidly improved their memory and cognitive function to that of the age-matched normal mice within a week.”

Before we go any further, we should make it clear that these results are restricted to mice only, and at this stage, we have no idea if they will translate at all in humans with Alzheimer’s.

And the odds aren’t great — one study put successful translation of positive results in mice to humans at a rate of about 8 percent, so we can never get too excited until we see how things fare in human trials.

Reinvent Yourself: The Playboy Interview with Ray Kurzweil

Many think author, inventor and data scientist Ray Kurzweil is a prophet for our digital age. A few say he’s completely nuts. Kurzweil, who heads a team of more than 40 as a director of engineering at Google, believes advances in technology and medicine are pushing us toward what he calls the Singularity, a period of profound cultural and evolutionary change in which computers will outthink the brain and allow people—you, me, the guy with the man-bun ahead of you at Starbucks—to live forever. He dates this development at 2045.

Raymond Kurzweil was born February 12, 1948, and he still carries the plain, nasal inflection of his native Queens, New York. His Jewish parents escaped Hitler’s Austria, but Kurzweil grew up attending a Unitarian church. He worshipped knowledge above all, and computers in particular. His grandmother was one of the first women in Europe to earn a Ph.D. in chemistry. His uncle, who worked at Bell Labs, taught Ray computer science in the 1950s, and by the age of 15, Kurzweil was designing programs to help do homework. Two years later, he wrote code to analyze and create music in the style of various famous composers. The program won him the prestigious Westinghouse Science Talent Search, a prize that got the 17-year-old an invitation to the White House. That year, on the game show I’ve Got a Secret, Kurzweil pressed some buttons on a data processor the size of a small car. It coughed out original sheet music that could have been written by Brahms.

After earning degrees in computer science and creative writing at MIT, he began to sell his inventions, including the first optical character recognition system that could read text in any normal font. Kurzweil knew a “reading machine” could help the blind, but to make it work, he first had to invent a text-to-speech synthesizer, as well as a flatbed scanner; both are still in wide use. In the 1980s Kurzweil created the first electronic music keyboard to replicate the sound of a grand piano and many other instruments. If you’ve ever been to a rock concert, you’ve likely seen the name Kurzweil on the back of a synthesizer.

/* */